Covera-HS en es it fr

Covera-HS Brand names, Covera-HS Analogs

Covera-HS Brand Names Mixture

  • Tarka (trandolapril + verapamil hydrochloride)

Covera-HS Chemical_Formula

C27H38N2O4

Covera-HS RX_link

http://www.rxlist.com/cgi/generic/verapsr.htm

Covera-HS fda sheet

Covera-HS FDA

Covera-HS msds (material safety sheet)

Covera-HS Synthesis Reference

Dengel, U.S. Pat. 3,261,859 (1966)

Covera-HS Molecular Weight

454.602 g/mol

Covera-HS Melting Point

< 25 oC

Covera-HS H2O Solubility

4.47 mg/L

Covera-HS State

Liquid

Covera-HS LogP

5.931

Covera-HS Dosage Forms

Capsule (sustained-release); Liquid; Solution; Tablet; Tablet (extended-release)

Covera-HS Indication

For the treatment of hypertension and angina.

Covera-HS Pharmacology

Verapamil, a class IV antiarrhythmic agent, is used as a calcium-channel blocking (CCB) agent for the treatment of angina, hypertension, and for supraventricular tachyarrhythmias.

Covera-HS Absorption

90%

Covera-HS side effects and Toxicity

LD50=8 mg/kg (i.v. in mice)

Covera-HS Patient Information

Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

Covera-HS Organisms Affected

Humans and other mammals